Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC90B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CREBL2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CNTN5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OGT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LMAN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SOCS5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HERC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR22 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEL1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FUT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLRC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCSK5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LEPROT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POC1B-GALNT4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CSNK1G3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DOCK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RIOK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HCCS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on